Evidence map›Paper›PMID 42980969›Full record

ReviewDiscover nano2026

Fluorescence-based biosensing with DNA nanostructures and DNA origami: from programmable architectures to quantitative readouts.

Seoyoung Kim, Min Yu Choi, Hyoyoung Jeong, Ha Rim Ahn, Jin-Ha Choi

Abstract readReview
In one paragraph

Review in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seoyoung KimSchool of Chemical Engineering, Jeonbuk National University, 567 Baekje- daero, Deokjin-gu, Jeonju-si, 54896, Jeonbuk State, Republic of Korea.
Min Yu ChoiSchool of Chemical Engineering, Jeonbuk National University, 567 Baekje- daero, Deokjin-gu, Jeonju-si, 54896, Jeonbuk State, Republic of Korea.
Hyoyoung JeongElectrical and Computer Engineering, University of California, Davis, One Shields Avenue, Davis, CA, 95616, United States of America.
Ha Rim Ahn *Department of Surgery, Jeonbuk National University Medical School, Jeonju-si, 54907, Republic of Korea.
Jin-Ha Choi *School of Chemical Engineering, Jeonbuk National University, 567 Baekje- daero, Deokjin-gu, Jeonju-si, 54896, Jeonbuk State, Republic of Korea. jhchoi@jbnu.ac.kr.ORCID https://orcid.org/0000-0002-1632-9586

Funding

National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) RS-2024-00406152
6 · The paper itself

Abstract

DNA nanotechnology and DNA origami have emerged as promising platforms for biosensing by exploiting the programmability of DNA sequences and structural self-assembly. Diverse DNA nanostructures, including three-way junctions (TWJs), dendritic assemblies, hydrogels, and tetrahedral DNA nanostructures (TDNs), provide structurally defined frameworks for the organization of functional components. DNA origami further enables highly programmable and precise spatial positioning by folding long DNA scaffolds with multiple staple strands. Their high biocompatibility and nanoscale spatial addressability allow the controlled organization of fluorophores, quenchers, aptamers, nanoparticles, and other functional components, which is particularly advantageous for fluorescence-based sensing strategies that rely on precise spatial control of these components. In this review, we first introduce the fundamental principles of fluorescence-based biosensing, including Förster resonance energy transfer (FRET) and plasmon-enhanced fluorescence (PEF). Then categorize DNA nanostructure-based fluorescence biosensors according to their structural architectures and sensing mechanisms. DNA origami-based platforms are subsequently classified based on their signal transduction strategies. Representative studies are discussed in terms of their design principles and sensing performance. We further critically discuss the remaining challenges, including structural stability, scalability, signal reproducibility, and clinical translation, and provide perspectives on the future development of next-generation fluorescence biosensing platforms enabled by programmable DNA architectures.

Indexed as

DNA nanostructureDNA origamiFluorescence biosensingFörster resonance energy transfer (FRET)Plasmon-enhanced fluorescence (PEF)

Identifiers

PMID42980969
PMCPMC13737347

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.